News digest

Direktlink:
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4
Layoutbild
 
 

News digest

Results: 24
Sorted by:
  1 ||
News digest
Scientists at the Helmholtz Centre Munich have pinpointed new gene variants responsible for disturbances in the lipid metabolism. Pictured above are fat cells derived from stem cells. 03.01.2010

News digest from the German biotech sector

Genetic background of metabolic disturbances revealed +++ Stem cell chip highlights brain damage +++ 37 million euros for Protein Research Centre in Bochum +++ 70 million euros for research excellence in East Germany +++ Curetis AG brings in 18.5 million euros

Smiles for catalysis research: the new institute's director Notker Rösch, architect Reinhart Sänger, Bavarian science minister Wolfgang Heubisch, president of the TUM Wolfgang Herrmann and the mayor of Garching, Hannelore Gabor 02.09.2009

News digest from the German biotech sector

One cell suffices for human stem cells +++ Green genetic engineering swirls up election campaign +++ Qiagen in 30 million-euro expansion in Hilden +++ Green genetic engineering: Politics promotes "No GM"; Industry wants the opposite +++ Success and disappointment with generic biotech drugs +++ Drug resistant fish provide genetic set for anti-addictive +++ 57 million euros for Munich catalysis centre

Berlin researchers have identified the genetic fingerprint for colorectal cancer. Here the tumor cells are bonded. 03.08.2009

News digest from the German biotech sector

Micromet pulls in 50 million euros on the money market +++ Colorectal cancer: Genetic fingerprint for metastasis identified +++ Independent development for versatile testicular stem cells +++ German Federal states invest millions in biotechnology +++ EMEA halts the march of Merck's Erbitux +++ Target for new antibiotics discovered

The Helmholtz Association started a new research program focused on BioInterfaces. This image shows growing cells on a threedimensional coated glass structure. 03.07.2009

News digest from the German biotech sector

Gentler treatment for autoimmune diseases +++ Helmholtz Association: 20 million for BioInterface program +++ Preventing organ transplant rejection +++ New tools for tuberculosis vaccine +++ Swine flu detection without symptoms +++ Wallets out for BioNTech in Mainz +++ GPC changes into Agennix

Most German biotech companies are defying the economic and financial crisis. 04.06.2009

News digest from the German biotech sector

New blood test for Alzheimer’s diagnosis +++ Tears substance finds use as cancer therapy tool +++ Therapeutic effect in inflammatory nerve diseases decrypted +++ Sanofi-Aventis to invest 63 million euros in Frankfurt +++ German biotech branch growing despite crisis +++ Resistance mechanism explained for ovarian cancer therapy +++

Chronic inflammatory bowel diseases such as Crohn's disease or ulcerative colitis are the result of an over-reaction of the immune system to bacteria from the normal intestinal flora. 04.05.2009

News digest from the German biotech sector

Bayer CropScience pulls agrobiotechnology out of Potsdam +++ Repairing the heart using stem cells +++ Economic stimulus package for biotechnology +++ Red biotechnology: growing and growing +++ Probiotic foods halt intestinal inflammation +++ German Parliament adopts Gene Diagnosis Law

Scientists from Lübeck and Kiel investigated a total of one million genetic markers from 1,200 patients with and without myocardial infarction. 02.03.2009

News digest from the German biotech sector

GPC find merger partners +++ Qiagen to invest in the location Germany +++ New genes discovered for cardiac infarction +++ New EMEA Committee under German leadership +++ Atherosclerosis as a malfunction of the body’s own immune system +++ On the hunt for asthma genes

The bioeconomy council at its first meeting: Hans Kast, Thomas Hirt, Bernd Müller-Röber, Andreas J. Büchting, Fritz Vahrenholt, Reinhard F. Hüttl, Carsten Thoroe, Wiltrud Treffenfeldt, Christian Patermann, Helmut Born, Achim Bachem and Manfred Schwerin (left to right) 02.02.2009

News digest from the German biotech sector

Bioeconomy council begins work +++ Pigs in sight as organ donors +++ Qiagen heads EU-funded project on sample standards +++ Wilex and UCB exchange money and know-how +++ Enzyme detective discovers virus genome +++ Epilepsy apparently caused by gaps in the chromosome

The green colour of the surface water off the Namibian coast is caused by toxic hydrosulfide released from the oecean ground. 31.12.2008

News digest from the German biotech sector

Transgenic stem cells implanted in the brain +++ MPI researchers develop free computer program for protein analysis +++ Prosecutor investigating against stem cell researcher +++ 2009 to be a difficult year +++ Profos AG goes bankrupt +++ Evotec boss quits +++  European Food Safety Authority opinion on Amflora delayed +++ GM soya import allowed

Almost every molecular biology laboratory in the world uses reagent containers made out of propylene for their studies and experiments. 28.11.2008

News digest from the German biotech sector

Pfizer shuts down production +++ Sygnis pulls in seven-figure funds +++ CIA invests in Germany +++ Record investment in Ganymed +++ Research may be distorted by plastic vessels +++ Cause of premature aging identified +++ Reducing pain without dulling the mind +++ Fat-reducing substance against Alzheimer's +++ Stem cell patent rejected

Results: 24
Sorted by:
  1 ||